| Analysis | Samples | Factors | Units |
|---|---|---|---|
| HILIC POSITIVE ION MODE | 71_irbcs_p_1 | cell_type:iRBC | treatment:Compound 3 | relative intensity |
| HILIC POSITIVE ION MODE | 71_irbcs_p_2 | cell_type:iRBC | treatment:Compound 3 | relative intensity |
| HILIC POSITIVE ION MODE | 71_irbcs_p_3 | cell_type:iRBC | treatment:Compound 3 | relative intensity |
| HILIC POSITIVE ION MODE | 71_irbcs_p_4 | cell_type:iRBC | treatment:Compound 3 | relative intensity |
| HILIC POSITIVE ION MODE | DMSO_iRBC_p_1 | cell_type:iRBC | treatment:DMSO | relative intensity |
| HILIC POSITIVE ION MODE | DMSO_iRBC_p_2 | cell_type:iRBC | treatment:DMSO | relative intensity |
| HILIC POSITIVE ION MODE | DMSO_iRBC_p_3 | cell_type:iRBC | treatment:DMSO | relative intensity |
| HILIC POSITIVE ION MODE | DMSO_iRBC_p_4 | cell_type:iRBC | treatment:DMSO | relative intensity |
| HILIC POSITIVE ION MODE | DMSO_iRBC_p_5 | cell_type:iRBC | treatment:DMSO | relative intensity |
| HILIC POSITIVE ION MODE | DMSO_iRBC_p_6 | cell_type:iRBC | treatment:DMSO | relative intensity |
| HILIC POSITIVE ION MODE | DMSO_iRBC_p_7 | cell_type:iRBC | treatment:DMSO | relative intensity |
| HILIC POSITIVE ION MODE | DMSO_iRBC_p_8 | cell_type:iRBC | treatment:DMSO | relative intensity |
| HILIC POSITIVE ION MODE | DMSO_iRBC_p_9 | cell_type:iRBC | treatment:DMSO | relative intensity |
| HILIC NEGATIVE ION MODE | 71_irbcs_p_1 | cell_type:iRBC | treatment:Compound 3 | relative intensity |
| HILIC NEGATIVE ION MODE | 71_irbcs_p_2 | cell_type:iRBC | treatment:Compound 3 | relative intensity |
| HILIC NEGATIVE ION MODE | 71_irbcs_p_3 | cell_type:iRBC | treatment:Compound 3 | relative intensity |
| HILIC NEGATIVE ION MODE | 71_irbcs_p_4 | cell_type:iRBC | treatment:Compound 3 | relative intensity |
| HILIC NEGATIVE ION MODE | DMSO_iRBC_p_1 | cell_type:iRBC | treatment:DMSO | relative intensity |
| HILIC NEGATIVE ION MODE | DMSO_iRBC_p_2 | cell_type:iRBC | treatment:DMSO | relative intensity |
| HILIC NEGATIVE ION MODE | DMSO_iRBC_p_3 | cell_type:iRBC | treatment:DMSO | relative intensity |
| HILIC NEGATIVE ION MODE | DMSO_iRBC_p_4 | cell_type:iRBC | treatment:DMSO | relative intensity |
| HILIC NEGATIVE ION MODE | DMSO_iRBC_p_5 | cell_type:iRBC | treatment:DMSO | relative intensity |
| HILIC NEGATIVE ION MODE | DMSO_iRBC_p_6 | cell_type:iRBC | treatment:DMSO | relative intensity |
| HILIC NEGATIVE ION MODE | DMSO_iRBC_p_7 | cell_type:iRBC | treatment:DMSO | relative intensity |
| HILIC NEGATIVE ION MODE | DMSO_iRBC_p_8 | cell_type:iRBC | treatment:DMSO | relative intensity |
| HILIC NEGATIVE ION MODE | DMSO_iRBC_p_9 | cell_type:iRBC | treatment:DMSO | relative intensity |
Return to study ST002108 main page
Download data matrix(Genetic and chemical validation of Plasmodium falciparum aminopeptidase PfA-M17 as a drug target in the hemoglobin digestion pathway (Part 3) HILIC POSITIVE ION MODE)
Download data matrix(Genetic and chemical validation of Plasmodium falciparum aminopeptidase PfA-M17 as a drug target in the hemoglobin digestion pathway (Part 3) HILIC NEGATIVE ION MODE)
- Metabolomics Workbench
|